La Sociedad FSHD celebra el hito de Fulcrum en la lucha contra la FSHD
Publicado el 8 de septiembre de 20239/8/23
Fulcrum Therapeutics has announced successful completion of patient enrollment in REACH Phase 3 trial The FSHD Society is thrilled to announce a significant milestone in the battle against FSHD. Fulcrum […]